Brainstorm Cell Theraputc (BCLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,790 | -8,488 | -7,104 | -4,501 | -2,236 |
| Depreciation Amortization | 219 | 922 | 1,028 | 715 | 370 |
| Accounts receivable | 269 | 204 | 119 | 671 | 309 |
| Other Working Capital | -1,441 | 43 | -156 | 84 | -78 |
| Other Operating Activity | -238 | -89 | -4 | -556 | -302 |
| Operating Cash Flow | $-2,981 | $-7,408 | $-6,117 | $-3,587 | $-1,937 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 4,794 | -11,237 | -12,151 | -14,104 | -13,565 |
| PPE Investments | -26 | -45 | -28 | -16 | N/A |
| Purchase Of Investment | -2 | -1 | -2 | N/A | N/A |
| Investing Cash Flow | $4,766 | $-11,283 | $-12,181 | $-14,120 | $-13,565 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 14,868 | 14,757 | 14,757 | 14,745 |
| Financing Cash Flow | $N/A | $14,868 | $14,757 | $14,757 | $14,745 |
| Beginning Cash Position | 428 | 4,251 | 4,251 | 4,251 | 4,251 |
| End Cash Position | 2,213 | 428 | 710 | 1,301 | 3,494 |
| Net Cash Flow | $1,785 | $-3,823 | $-3,541 | $-2,950 | $-757 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,981 | -7,408 | -6,117 | -3,587 | -1,937 |
| Capital Expenditure | -26 | -45 | -28 | -16 | N/A |
| Free Cash Flow | -3,007 | -7,453 | -6,145 | -3,603 | -1,937 |